<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The vascular ectonucleotidase ENTPD1 protects against renal injury and modulates <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis in mouse models </plain></SENT>
<SENT sid="1" pm="."><plain>We sought to determine whether human variation in ENTPD1 influences predisposition to <z:mp ids='MP_0002055'>diabetes</z:mp> or diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We analyzed ENTPD1 single nucleotide polymorphisms (SNPs) in 363 African American control subjects, 380 subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> (DM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>), and 326 subjects with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> unrelated to <z:mp ids='MP_0002055'>diabetes</z:mp> (non-DM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Using human cell lines, we correlated disease-associated ENTPD1 haplotypes with ENTPD1 gene expression </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, we studied consequences of ENTPD1 deletion in a mouse model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (db/db) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A common ENTPD1 two-SNP haplotype was associated with increased risk for DM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> (P = 0.0027), and an uncommon four-SNP haplotype was associated with protection against DM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> (P = 0.004) </plain></SENT>
<SENT sid="6" pm="."><plain>These haplotypes correlated with ENTPD1 gene expression levels in human cell lines in vitro </plain></SENT>
<SENT sid="7" pm="."><plain>Subjects with high ENTPD1-expressing haplotypes were enriched in the DM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> group </plain></SENT>
<SENT sid="8" pm="."><plain>By crossing ENTPD1-null mice with db mice, we show that ENTPD1 deletion has prominent effects on <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> traits </plain></SENT>
<SENT sid="9" pm="."><plain>Specifically, deletion of ENTPD1 lowered <z:chebi fb="105" ids="17234">glucose</z:chebi> levels in control (db/-) mice with one functional leptin receptor and dramatically lowered weights in db/db mice with no functional leptin receptors </plain></SENT>
<SENT sid="10" pm="."><plain>Similar effects were seen in aged ENTPD1-null mice with <z:mpath ids='MPATH_458'>normal</z:mpath> leptin receptors </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: ENTPD1 polymorphisms appear to influence susceptibility to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and/or diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in African Americans </plain></SENT>
<SENT sid="12" pm="."><plain>Studies in human cell lines and in vivo mouse data support a potential role for ENTPD1 genetic variation in susceptibility to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>